Health care procurement news: February 2021
Lawmakers cite our research to urge safer medical products
Infant in NICU watches cow toy (Christian Wilcox/Flickr)
Six members of Congress are demanding federal regulators take steps to remove phthalates and other hormone-disrupting chemicals from medical products, especially IV bags and neonatal equipment. Citing Health Care Without Harm’s analysis on PVC and DEHP and evidence from U.S. and European sources, the lawmakers are concerned about patient health risks associated with these toxins and are urging long-overdue action.
Making medical products safer
Webinar: Navigating chemicals of concern in health care
Join the United Nations Development Programme and Health Care Without Harm in the launch of their new report: “Chemicals of concern for the health sector.”
On Feb. 25 at 9 a.m. ET, experts will discuss a global perspective of chemicals used in the health care sector, as some of them may pose environmental or health hazards. This online session will demonstrate how hospitals have successfully substituted chemicals and products with safer alternatives.
Register for free
How hospitals can protect workers, our new ethical food purchasing guidance and position statement
Health care can play a critical role in protecting workers, community health, and the planet through procurement and advocacy. Health Care Without Harm has conducted a comprehensive review of third-party certifications and label claims to determine how each addresses different aspects of farmworker health and safety.
We are proud to release our position statement and purchasing guidance on ethical food purchasing. A team of researchers from Mark Bittman’s course at the Mailman School of Public Health at Columbia University contributed to the development of these resources and the corresponding Feb. 11 webinar.
Ethical procurement
Learn more about our work in sustainable procurement and how you can get involved.
